Search

Your search keyword '"C. Jackisch"' showing total 624 results

Search Constraints

Start Over You searched for: Author "C. Jackisch" Remove constraint Author: "C. Jackisch"
624 results on '"C. Jackisch"'

Search Results

1. Hydro-pedotransfer functions: a roadmap for future development

2. Soil water retention and hydraulic conductivity measured in a wide saturation range

3. P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib

5. Preface: Linking landscape organisation and hydrological functioning: from hypotheses and observations to concepts, models and understanding

6. Estimates of tree root water uptake from soil moisture profile dynamics

7. Soil moisture and matric potential – an open field comparison of sensor systems

8. A topographic index explaining hydrological similarity by accounting for the joint controls of runoff formation

10. Energy states of soil water – a thermodynamic perspective on soil water dynamics and storage-controlled streamflow generation in different landscapes

11. On the dynamic nature of hydrological similarity

12. Ecohydrological particle model based on representative domains

13. Form and function in hillslope hydrology: characterization of subsurface flow based on response observations

14. Form and function in hillslope hydrology: in situ imaging and characterization of flow-relevant structures

15. Unravelling abiotic and biotic controls on the seasonal water balance using data-driven dimensionless diagnostics

16. Picturing and modeling catchments by representative hillslopes

17. Estimating spatially distributed soil texture using time series of thermal remote sensing – a case study in central Europe

18. A Lagrangian model for soil water dynamics during rainfall-driven conditions

19. HESS Opinions: From response units to functional units: a thermodynamic reinterpretation of the HRU concept to link spatial organization and functioning of intermediate scale catchments

20. Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response

22. Prädiktive molekulare Diagnostik beim Mammakarzinom

25. [Predictive molecular diagnostics in breast cancer : What are the requirements for pathology today and in the future?]

30. Corrigendum to 'A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study'

31. Präventionsprogramme der Landeskrebsgesellschaften

32. 58O Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment

35. 94P Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

37. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study

38. 168P Long-term survival of a randomised, open-label, phase II study comparing the efficacy and safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)

40. 200TiP A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC)- GeparPiPPa

42. 304P Incidence and resolution of eribulin-induced peripheral neuropathy (IRENE) in patients with locally advanced or metastatic breast cancer

43. Carboplatin/PLD/Bevacizumab als neue Standardtherapieoption beim Ovarialkarzinomspätrezidiv – aktuelle Ergebnisse der AGO OVAR 2.21 Studie

44. Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy

45. Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study)

46. Management of the axilla for high-risk early breast cancer (EBC) before and after neoadjuvant chemotherapy (NACT): an analysis of the multicentre GeparOcto trial

48. Abstract P2-08-01: Factors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy – Results of a pooled analysis based on the GBG meta-database

49. Abstract PD2-07: mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC)– Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial

50. Abstract P2-13-01: Efficacy of neratinib in hormone receptor-positive patients who initiated treatment within 1 year of completing trastuzumab-based adjuvant therapy in HER2+ early-stage breast cancer: Subgroup analyses from the phase III ExteNET trial

Catalog

Books, media, physical & digital resources